NCT01654731View on ClinicalTrials.gov

Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 15, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
PBC
Interventions
DRUG

Bezafibrate

DRUG

placebo

Trial Locations (1)

75012

Hepatology department - Hopital Saint Antoine, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01654731 - Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis | Biotech Hunter | Biotech Hunter